Prelude Capital Management’s CARGO Therapeutics CRGX Stock Holding History

Prelude Capital Management’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,141	Closed	-$91.2K	–	1182
2025 Q2	$91.2K	Sell	22,141 -15,459	-41%	-$66.2K	0.01%	925
2025 Q1	$153K	Buy	+37,600	New	+$252K	0.01%	988

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Prelude Capital Management's CRGX Position: Q3 2025 in Review

Prelude Capital Management sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 22,141 shares — an estimated $91.2K sold.

Prelude Capital Management first reported a position in CRGX in Q1 2025 and held it in 2 quarters. The position peaked at $153K in Q1 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Prelude Capital Management reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Prelude Capital Management sold 22,141 CARGO Therapeutics shares in Q3 2025, an estimated $91.2K.
Prelude Capital Management first reported a position in CARGO Therapeutics in Q1 2025 and held it in 2 quarters.
Prelude Capital Management's CARGO Therapeutics position peaked at $153K in Q1 2025.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.